Controller at Astro-Med, Inc. (NASDAQ:ALOT) J. Erik Mancyak has acquired 13,325 shares of common stock, at prices ranging from $ 6.22 to $ 11.90. The stock was procured under Rule 16b-3. This $105.63 million Market Cap technology company hadn’t seen any insider acquisition since 2011, when Director Graeme Macletchie acquired 2,500 shares, at a price of $6.95 per share.
In contrast, several insider sells have been registered over the past reported quarters 2014. Director Everett Pizzuti sold 152,000 shares, at average price of $12, and Vice Presidents W. Gordon Bentley, M Stephen Petrarca, E Eric Pizzuti, sold respectively 5,000 shares, at a price of $13.82, 10,941 shares, at average price of $ 12.16, and 5,025 shares, priced $12 per share.
Additionally, John W. Rogers’s Ariel Investments hedge fund increased its stake at Astro-Med, Inc. (NASDAQ:ALOT) by 1%, holding 925,538 shares, worth more than $11 million, and accounting for 0.13% of the fund’s Equity Portfolio. Peter Schliemann’s Rutabaga Capital Management didn’t feel so bullish about this stock the last reported quarter, reducing its activity by 3%, currently holding about 650,000 shares, valued at $7,800 million.
Disclosure: None.
Suggested Reading:
The 10 Fastest Growing Companies in America
The 10 Countries that Eat the Most Meat
